Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study.
Goodwin PJ, Phillips KA, West DW, Ennis M, Hopper JL, John EM, O'Malley FP, Milne RL, Andrulis IL, Friedlander ML, Southey MC, Apicella C, Giles GG, Longacre TA. Goodwin PJ, et al. Among authors: west dw. J Clin Oncol. 2012 Jan 1;30(1):19-26. doi: 10.1200/JCO.2010.33.0068. Epub 2011 Dec 5. J Clin Oncol. 2012. PMID: 22147742
No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages <50 years.
McGuire V, John EM, Felberg A, Haile RW, Boyd NF, Thomas DC, Jenkins MA, Milne RL, Daly MB, Ward J, Terry MB, Andrulis IL, Knight JA, Godwin AK, Giles GG, Southey M, West DW, Hopper JL, Whittemore AS; kConFab Investigators. McGuire V, et al. Among authors: west dw. Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1565-7. doi: 10.1158/1055-9965.EPI-06-0323. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16896052 No abstract available.
BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays.
Bane AL, Beck JC, Bleiweiss I, Buys SS, Catalano E, Daly MB, Giles G, Godwin AK, Hibshoosh H, Hopper JL, John EM, Layfield L, Longacre T, Miron A, Senie R, Southey MC, West DW, Whittemore AS, Wu H, Andrulis IL, O'Malley FP. Bane AL, et al. Among authors: west dw. Am J Surg Pathol. 2007 Jan;31(1):121-8. doi: 10.1097/01.pas.0000213351.49767.0f. Am J Surg Pathol. 2007. PMID: 17197928
Prediagnosis reproductive factors and all-cause mortality for women with breast cancer in the breast cancer family registry.
Phillips KA, Milne RL, West DW, Goodwin PJ, Giles GG, Chang ET, Figueiredo JC, Friedlander ML, Keegan TH, Glendon G, Apicella C, O'Malley FP, Southey MC, Andrulis IL, John EM, Hopper JL. Phillips KA, et al. Among authors: west dw. Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1792-7. doi: 10.1158/1055-9965.EPI-08-1014. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19505912 Free PMC article.
Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry.
Kurian AW, Gong GD, John EM, Johnston DA, Felberg A, West DW, Miron A, Andrulis IL, Hopper JL, Knight JA, Ozcelik H, Dite GS, Apicella C, Southey MC, Whittemore AS. Kurian AW, et al. Among authors: west dw. J Clin Oncol. 2011 Dec 1;29(34):4505-9. doi: 10.1200/JCO.2010.34.4440. Epub 2011 Oct 31. J Clin Oncol. 2011. PMID: 22042950 Free PMC article.
Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers.
John EM, McGuire V, Thomas D, Haile R, Ozcelik H, Milne RL, Felberg A, West DW, Miron A, Knight JA, Terry MB, Daly M, Buys SS, Andrulis IL, Hopper JL, Southey MC, Giles GG, Apicella C, Thorne H; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab); Whittemore AS. John EM, et al. Among authors: west dw. Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1547-56. doi: 10.1158/1055-9965.EPI-13-0189. Epub 2013 Jul 12. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23853209 Free PMC article.
Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations.
Milne RL, Knight JA, John EM, Dite GS, Balbuena R, Ziogas A, Andrulis IL, West DW, Li FP, Southey MC, Giles GG, McCredie MR, Hopper JL, Whittemore AS. Milne RL, et al. Among authors: west dw. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):350-6. doi: 10.1158/1055-9965.EPI-04-0376. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15734957
Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry.
Chang ET, Milne RL, Phillips KA, Figueiredo JC, Sangaramoorthy M, Keegan TH, Andrulis IL, Hopper JL, Goodwin PJ, O'Malley FP, Weerasooriya N, Apicella C, Southey MC, Friedlander ML, Giles GG, Whittemore AS, West DW, John EM. Chang ET, et al. Among authors: west dw. Breast Cancer Res Treat. 2009 Sep;117(1):167-76. doi: 10.1007/s10549-008-0255-3. Epub 2008 Nov 26. Breast Cancer Res Treat. 2009. PMID: 19034644 Free PMC article.
Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry.
Kurian AW, Gong GD, John EM, Miron A, Felberg A, Phipps AI, West DW, Whittemore AS. Kurian AW, et al. Among authors: west dw. Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1084-91. doi: 10.1158/1055-9965.EPI-08-1090. Epub 2009 Mar 31. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19336551 Free PMC article. Clinical Trial.
298 results